|Citation:||Xing Liu, Fei Yang, Yi Li, Zhen-Peng Yu, Xin Huang, Lin-Xia Sun, Wen-Hua Ren, Guang Yang, Shi-Xia Xu. Evolution of p53 pathway-related genes provides insights into anticancer mechanisms of natural longevity in cetaceans. Zoological Research, 2023, 44(5): 947-949. doi: 10.24272/j.issn.2095-8137.2023.058|
Abegglen LM, Caulin AF, Chan A, et al. 2015. Potential mechanisms for cancer resistance in elephants and comparative cellular response to DNA damage in humans.
Al-Ostoot FH, Salah S, Khamees HA, et al. 2021. Tumor angiogenesis: Current challenges and therapeutic opportunities.
Brugarolas JB, Vazquez F, Reddy A, et al. 2003. TSC2 regulates VEGF through mTOR-dependent and-independent pathways.
Cha HJ, Yim H. 2013. The accumulation of DNA repair defects is the molecular origin of carcinogenesis.
Gorbunova V, Seluanov A, Zhang ZD, et al. 2014. Comparative genetics of longevity and cancer: insights from long-lived rodents.
Nagy JD, Victor EM, Cropper JH. 2007. Why don't all whales have cancer? A novel hypothesis resolving Peto's paradox.
Peto R, Roe FJ, Lee PN, et al. 1975. Cancer and ageing in mice and men.
Tacutu R, Thornton D, Johnson E, et al. 2018. Human ageing genomic resources: new and updated databases.
Vellai T, Takacs-Vellai K, Zhang Y, et al. 2003. Influence of TOR kinase on lifespan in C. elegans. Nature, 426(6967): 620.
Wu JB, Strawn TL, Luo M, et al. 2015. Plasminogen activator inhibitor-1 inhibits angiogenic signaling by uncoupling vascular endothelial growth factor receptor-2-αVβ3 integrin cross talk.